Eltek Ltd. Reports 2025 First Quarter Financial Results
PETACH TIKVA, Israel,

First Quarter 202 5 Highlights
- Revenues were
$12.8 million - Operating profit was
$0.7 million - Net income was
$1.0 million or$0.15 per fully diluted share - Net cash provided by operating activities amounted to
$0.1 million .
"We ended the first quarter of 2025 with revenues of
"Looking ahead to the remainder of the year, we continue to advance our investment program as planned. Our forecast that we will complete the accelerated investment plan by mid-2026 remains unchanged. We are undertaking all necessary preparations to ensure the swift and efficient integration of the new lines, with the goal of bringing them into full production," continued
"On the revenue side, we continue to experience strong demand for the Company's products, and we are seeing lead times increase across all our relevant market sectors. As previously communicated, we are actively working to expand the scope of our commercial sales—an effort that we anticipate will bear fruit during the rest of 2025 and in the years to follow," concluded
First Quarter 2025 GAAP Financial Results
Revenues for the first quarter of 2025 were
Gross profit for the first quarter of 2025 was
Operating profit for the first quarter of 2025 was
Net income for the first quarter of 2025 was
Cash and short-term bank deposits amounted to
First Quarter 2025 Non-GAAP Financial Results
EBITDA for the first quarter of 2025 was
Conference Call
Today,
To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:
Israel: 03-918-0691
International: +972-3-918-0691
To Access a Replay of the Call
A replay of the call will be available for 30 days on the Investor Info section on
About
For more information, visit
Forward Looking Statements
Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties including, but not limited to expected results in future quarters, the impact of the Coronavirus on the economy and our operations, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company's Annual Report on Form 20-F and other filings with the
About our Non-GAAP Financial Information
The Company reports financial results in accordance with
Investor Contact
Chief Financial Officer
Investor-Contact@nisteceltek.com
+972-3-939-5023
|
|||||||||
Consolidated Statements of Income |
|||||||||
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
||||
|
|
|
|
|
|
||||
|
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
Revenues |
|
12,756 |
|
11,783 |
|
|
|
|
|
Costs of revenues |
|
(10,544) |
|
(8,531) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
2,212 |
|
3,252 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development, expenses, net |
|
(50) |
|
(15) |
|
|
|
|
|
Selling, general and administrative expenses |
|
(1,437) |
|
(1,516) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
725 |
|
1,721 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial income, net |
|
504 |
|
350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
1,229 |
|
2,071 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expenses |
|
227 |
|
332 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income |
|
1,002 |
|
1,739 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share: |
|
|
|
|
|
|
|
|
|
Basic net income per ordinary share |
|
0.15 |
|
0.27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income per ordinary share |
|
0.15 |
|
0.27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of ordinary shares used to compute |
|
|
|
|
|
|
|
|
|
basic net income per ordinary share (in thousands) |
|
6,714 |
|
6,376 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of ordinary shares used to compute |
|
|
|
|
|
|
|
|
|
diluted net income per ordinary share (in thousands) |
|
6,785 |
|
6,491 |
|
|
|
|
|
|
|||||||||
Consolidated Balance Sheets |
|||||||||
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
6,466 |
|
7,575 |
|
|
|
|
|
Short-term bank deposits |
|
9,257 |
|
9,663 |
|
|
|
|
|
Trade receivables (net of allowance for credit losses) |
|
12,284 |
|
11,786 |
|
|
|
|
|
Inventories |
|
9,978 |
|
9,488 |
|
|
|
|
|
Other accounts receivable and prepaid expenses |
|
726 |
|
602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
38,711 |
|
39,114 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long term assets: |
|
|
|
|
|
|
|
|
|
Severance pay fund |
|
55 |
|
56 |
|
|
|
|
|
Deferred tax assets, net |
|
322 |
|
496 |
|
|
|
|
|
Operating lease right of use assets |
|
5,988 |
|
5,911 |
|
|
|
|
|
Total long term assets |
|
6,365 |
|
6,463 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
15,999 |
|
14,578 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Assets |
|
61,075 |
|
60,155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Shareholder's equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
|
Trade payables |
|
7,615 |
|
7,367 |
|
|
|
|
|
Other accounts payable and accrued expenses |
|
5,389 |
|
5,136 |
|
|
|
|
|
Short-term operating lease liabilities |
|
936 |
|
827 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
13,940 |
|
13,330 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
|
Accrued severance pay |
|
450 |
|
443 |
|
|
|
|
|
Long-term operating lease liabilities |
|
5,157 |
|
5,190 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total long-term liabilities |
|
5,607 |
|
5,633 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
|
|
|
|
|
Ordinary shares,
and outstanding 6,714,040 at 31, 2024 |
|
6,011 |
|
6,011 |
|
|
|
|
|
Additional paid-in capital |
|
32,627 |
|
32,627 |
|
|
|
|
|
Foreign currency translation adjustments |
|
(140) |
|
664 |
|
|
|
|
|
Capital reserve |
|
2,645 |
|
2,507 |
|
|
|
|
|
Retained earnings (accumulated deficit) |
|
385 |
|
(617) |
|
|
|
|
|
Total shareholders' equity |
|
41,528 |
|
41,192 |
|
|
|
|
|
Total liabilities and shareholders' equity |
|
61,075 |
|
60,155 |
|
|
|
|
|
|
||||||||
Unaudited Non-GAAP EBITDA Reconciliations |
||||||||
|
||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
||||
|
|
|
|
|
||||
|
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
GAAP net Income |
|
1,002 |
|
1,739 |
|
|
|
|
Add back items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial income, net |
|
(504) |
|
(350) |
|
|
|
|
Income tax expenses |
|
227 |
|
332 |
|
|
|
|
Depreciation and amortization |
|
465 |
|
365 |
|
|
|
|
Non-GAAP EBITDA |
|
1,190 |
|
2,086 |
|
|
|
|
|
|||||||||
Consolidated Statements of Cash Flows |
|||||||||
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
||||
|
|
|
|
|
|
||||
|
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income |
|
1,002 |
|
1,739 |
|
|
|
|
|
Adjustments to reconcile net income to net cash flows |
|
|
|
|
|
|
|
|
|
provided by operating activities: |
|
|
|
|
|
|
|
|
|
Depreciation |
|
465 |
|
365 |
|
|
|
|
|
Accrued interest, net |
|
(128) |
|
- |
|
|
|
|
|
Share-based compensation |
|
138 |
|
132 |
|
|
|
|
|
Decrease in deferred tax assets |
|
82 |
|
322 |
|
|
|
|
|
|
|
557 |
|
819 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decrease (increase) in operating lease right-of-use assets |
|
1 |
|
1 |
|
|
|
|
|
Decrease (increase) in trade receivables |
|
(355) |
|
736 |
|
|
|
|
|
Decrease (increase) in other receivables and prepaid expenses |
|
(67) |
|
75 |
|
|
|
|
|
Decrease (increase) in inventories |
|
(330) |
|
(396) |
|
|
|
|
|
Increase (decrease) in trade payables |
|
(862) |
|
(1,491) |
|
|
|
|
|
Increase (decrease) in other liabilities and accrued expenses |
|
173 |
|
(201) |
|
|
|
|
|
Increase (decrease) in employee severance benefits, net |
|
7 |
|
18 |
|
|
|
|
|
|
|
(1,433) |
|
(1,258) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
126 |
|
1,300 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
Purchase of fixed assets |
|
(1,137) |
|
(2,731) |
|
|
|
|
|
Withdrawal of (investment in) short-term bank deposits, net |
|
534 |
|
(6,490) |
|
|
|
|
|
Net cash used in investing activities |
|
(603) |
|
(9,221) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
Exercise of options |
|
- |
|
246 |
|
|
|
|
|
Repayment of long-term loans from bank |
|
- |
|
- |
|
|
|
|
|
Issuance of shares, net |
|
- |
|
9,180 |
|
|
|
|
|
Net cash provided by (used in) financing activities |
|
- |
|
9,426 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of translation adjustments |
|
(632) |
|
(173) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents |
|
(1,109) |
|
1,332 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at the beginning of the period |
|
7,575 |
|
9,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at the end of the period |
|
6,466 |
|
10,610 |
|
|
|
|
|
Logo - https://mma.prnewswire.com/media/881148/Eltek_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/eltek-ltd-reports-2025-first-quarter-financial-results-302460221.html
SOURCE